Stada Recruits Ex-Sandoz Exec To Help Steer Biosimilars

Christine Berndt Previously Headed Biosimilar Development Programs At Sandoz

 
• By David Wallace
Wooden blocks leader selected chosen people put forward
Christine Berndt will be head of global development for specialty/biosimilar drugs at Stada • Source: Paradee Kietsirikul / Alamy Stock Photo

More from Leadership

More from Generics Bulletin